Checked: not set yet by
vicky.ryan Next Review: 25-05-2018
GORD NS MOM
Map of Medicine is not responsible for the correctness or accuracy of any content uploaded, referred to or linked to from the system.
Efforts are made to ensure the accuracy and agreement of these guidelines. However, we cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties
primary care assessment and management of dyspepsia in adults
indications for referral for endoscopy
Out of scope:
dyspepsia is defined as :
upper abdominal pain or discomfort
present for at least 4 weeks 
 National Institute for Health and Clinical Excellence (NICE). Dyspepsiaand gastro-oesophageal reflux disease: Investigation and management of dyspepsia, symptoms suggestive of GORD, or both in Clinical guideline 184. London: NICE; 2014.
 Contributors representing the Royal College of Physicians; 2011.
 Clinical Knowledge Summaries (CKS). Dyspepsia - proven non-ulcer. November 2012. Newcastle upon Tyne: CKS; 2012.
 Scottish Intercollegiate Guidelines Network (SIGN). Dyspepsia. A national clinical guideline. Publication no. 68. Edinburgh: SIGN; 2003.
 Health Protection Agency (HPA). Diagnosis of Helicobacter pylori (HP) in Dyspepsia. Quick Reference Guide for Primary Care. London: HPA; 2012.
 Clinical Knowledge Summaries (CKS). Dyspepsia – proven gastro-oesophageal reflux disease. November 2012. Newcastle upon Tyne: CKS; 2012.
 Health Protection Agency (HPA). UK Standards for Microbiology Investigations: Investigation of Gastric Biopsies for Helicobacter pylori . London: HPA; 2012.
 McColl K. Helicobacter pylori infection. N Engl J Med 2010; 362: 1597-604.
 Donnellan C, Sharma N, Preston C et al. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005; CD003245.
 El-Serag H, Becher A, Jones R et al. Systematic review: Persistent reflux symptoms on PPI therapy in primary care & community studies. Aliment Pharmacol Therap 2010; 32: 720-37.
 Raghunath AS, Hungin APS, Mason J et al. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors. Aliment Pharmacol Therap 2009; 29: 431-9.
 Zullo A, De F, V, Hassan C et al. Modified sequential therapy regimens for Helicobacter pylori eradication: a systematic review. Dig Liver Dis 2013; 45: 18-22.
 Di Caro S, Fini L, Daoud Y et al. Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line. World J Gastroenterol 2012; 18: 5669-78.
 Clinical Knowledge Summaries (CKS). Dyspepsia - unidentified cause. November 2012. Newcastle upon Tyne: CKS; 2012.
 Alumm WH, Blazeby JM, Griffin SM et al. Guidelines for the management of oesophageal and gastric cancer. London: Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology, the British Association of Surgical Oncology; 2011.